Skip to main content

Hirsuitism

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Combined Therapeutics
1 program
IPLN/A2 trials
Active Trials
NCT07779811Not Yet Recruiting104Est. Jan 2027
NCT05739799Completed60Est. Nov 2022

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
Combined TherapeuticsIPL
Combined TherapeuticsIPL

Clinical Trials (2)

Total enrollment: 164 patients across 2 trials

Topical Metformin Versus Triple Regimen for Epidermal Melasma

Start: Aug 2026Est. completion: Jan 2027104 patients
Phase 2Not Yet Recruiting

To Comapre The Effectiveness of Two Lasers in The Treamment of Unwanted Hair

Start: May 2022Est. completion: Nov 202260 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.